Heart Test Earnings Estimate

HSCS Stock  USD 3.78  0.03  0.80%   
The next projected EPS of Heart Test is estimated to be -2.38625 with future projections ranging from a low of -2.5 to a high of -2.2725. Heart Test's most recent 12-month trailing earnings per share (EPS TTM) is at -7.61. Please be aware that the consensus of earnings estimates for Heart Test Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Heart Test is projected to generate -2.38625 in earnings per share on the 30th of April 2025. Heart Test earnings estimates show analyst consensus about projected Heart Test Laboratories EPS (Earning Per Share). It derives the highest and the lowest estimates based on Heart Test's historical volatility. Many public companies, such as Heart Test, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Heart Test's earnings estimates, investors can diagnose different trends across Heart Test's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to drop to 8,643 in 2025Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Heart Test Earnings Estimation Breakdown

The calculation of Heart Test's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Heart Test is estimated to be -2.38625 with the future projection ranging from a low of -2.5 to a high of -2.2725. Please be aware that this consensus of annual earnings estimates for Heart Test Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-2.57
-2.5
Lowest
Expected EPS
-2.38625
-2.27
Highest

Heart Test Earnings Projection Consensus

Suppose the current estimates of Heart Test's value are higher than the current market price of the Heart Test stock. In this case, investors may conclude that Heart Test is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Heart Test's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 30th of April 2025Current EPS (TTM)
259.28%
-2.57
-2.38625
-7.61

Heart Test Earnings per Share Projection vs Actual

Actual Earning per Share of Heart Test refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Heart Test Laboratories predict the company's earnings will be in the future. The higher the earnings per share of Heart Test, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Heart Test Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Heart Test, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Heart Test should always be considered in relation to other companies to make a more educated investment decision.

Heart Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Heart Test's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-03-20
2025-01-31-2.305-2.57-0.26511 
2024-12-17
2024-10-31-2.335-2.270.065
2024-09-12
2024-07-31-2.46-2.64-0.18
2024-07-17
2024-04-30-0.13-18.81-18.6814369 
2024-03-14
2024-01-31-0.06-0.030.0350 
2023-12-14
2023-10-31-0.12-0.16-0.0433 
2023-09-14
2023-07-31-0.14-0.130.01
2023-07-19
2023-04-30-0.16-0.21-0.0531 
2023-03-16
2023-01-31-0.16-0.160.0
2022-12-15
2022-10-31-0.33-0.220.1133 
2022-09-12
2022-07-31-0.28-0.280.0

About Heart Test Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Heart Test earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Heart Test estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Heart Test fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-60.6 M-63.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.